Evidence map›Paper›PMID 42614512›Full record

ArticleHealth SA = SA Gesondheid2025

Recruiters' lived experiences in COVID-19 vaccine trials in eThekwini, KwaZulu-Natal.

Kumari Dewrance, Shenuka Singh

Abstract read
In one paragraph

Article in Health SA = SA Gesondheid, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kumari DewranceSchool of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.ORCID https://orcid.org/0009-0009-6067-2646
Shenuka SinghDiscipline of Dentistry, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.ORCID https://orcid.org/0000-0003-4842-602X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The coronavirus disease 2019 (COVID-19) pandemic led to widespread COVID-19 vaccine trials globally, with South Africa hosting many of these studies. Participant recruitment for these trials has been hindered by vaccine hesitancy, misinformation, distrust and pandemic-related restrictions. Aim: This study explored the experiences and perceptions of recruiters involved in COVID-19 vaccine trials in eThekwini, KwaZulu-Natal, focusing on recruitment facilitators, barriers and strategies. Setting: Six clinical trial sites in eThekwini, KwaZulu-Natal. Methods: Using a qualitative phenomenological approach within an interpretive paradigm, researchers conducted in-depth online interviews via Microsoft Teams with 14 recruiters selected through non-probability purposive sampling. Field notes supplemented the interviews, and thematic analysis with open coding identified key themes. Results: Analysis of recruiters' lived experiences revealed four main themes: (1) motivations driving participation, (2) barriers faced in the field, (3) strategies used to engage communities and facilitate enrolment and (4) recruiters' insights for improving future recruitment success. Conclusion: This study identified the difficulties recruiters faced in enrolling participants in COVID-19 vaccine trials in eThekwini, and the reasons why participants chose to take part. Insights from recruiters can inform strategies to strengthen participant recruitment in future clinical trials. Contribution: This research provides context-specific recommendations for improving recruitment during public health emergencies, with implications for future trials in similar settings.

Indexed as

COVID-19 vaccine trialsKwaZulu-Natallived experiencesperspectivesrecruitersrecruitmentSouth Africa

Identifiers

PMID42614512
PMCPMC13482079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.